non small cell lung cancer cell lines a549 Search Results


90
Jingzhou Natural Astaxanthin a549 non-small-cell lung cancer cells
A549 Non Small Cell Lung Cancer Cells, supplied by Jingzhou Natural Astaxanthin, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/a549 non-small-cell lung cancer cells/product/Jingzhou Natural Astaxanthin
Average 90 stars, based on 1 article reviews
a549 non-small-cell lung cancer cells - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Pharmaseed Ltd a549 human non-small-cell lung carcinoma cells
A549 Human Non Small Cell Lung Carcinoma Cells, supplied by Pharmaseed Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/a549 human non-small-cell lung carcinoma cells/product/Pharmaseed Ltd
Average 90 stars, based on 1 article reviews
a549 human non-small-cell lung carcinoma cells - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Chennai Corporation cell line lung cancer (a549)
Comparative analysis of nanostructured CuS NPs against inhibition of different cancer cells
Cell Line Lung Cancer (A549), supplied by Chennai Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cell line lung cancer (a549)/product/Chennai Corporation
Average 90 stars, based on 1 article reviews
cell line lung cancer (a549) - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Guiyang Xintian Pharmaceutical Co Ltd akebia trifoliata
Comparative analysis of nanostructured CuS NPs against inhibition of different cancer cells
Akebia Trifoliata, supplied by Guiyang Xintian Pharmaceutical Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/akebia trifoliata/product/Guiyang Xintian Pharmaceutical Co Ltd
Average 90 stars, based on 1 article reviews
akebia trifoliata - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
BioMimetic Therapeutics lung cancer cells a549/95-d
Comparative analysis of nanostructured CuS NPs against inhibition of different cancer cells
Lung Cancer Cells A549/95 D, supplied by BioMimetic Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lung cancer cells a549/95-d/product/BioMimetic Therapeutics
Average 90 stars, based on 1 article reviews
lung cancer cells a549/95-d - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
AtaGenix Inc pancreatic cancer cell line mia-paca-2
Comparative analysis of nanostructured CuS NPs against inhibition of different cancer cells
Pancreatic Cancer Cell Line Mia Paca 2, supplied by AtaGenix Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pancreatic cancer cell line mia-paca-2/product/AtaGenix Inc
Average 90 stars, based on 1 article reviews
pancreatic cancer cell line mia-paca-2 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
PeproTech human lung cancer cell line a549
Comparative analysis of nanostructured CuS NPs against inhibition of different cancer cells
Human Lung Cancer Cell Line A549, supplied by PeproTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human lung cancer cell line a549/product/PeproTech
Average 90 stars, based on 1 article reviews
human lung cancer cell line a549 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Panapharm Laboratories cell line a549 human lung cancer
Comparative analysis of nanostructured CuS NPs against inhibition of different cancer cells
Cell Line A549 Human Lung Cancer, supplied by Panapharm Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cell line a549 human lung cancer/product/Panapharm Laboratories
Average 90 stars, based on 1 article reviews
cell line a549 human lung cancer - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Evotec Inc a549 cell assays
Comparative analysis of nanostructured CuS NPs against inhibition of different cancer cells
A549 Cell Assays, supplied by Evotec Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/a549 cell assays/product/Evotec Inc
Average 90 stars, based on 1 article reviews
a549 cell assays - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
System Biosciences Inc human non-small cell lung cancer cells a549
Comparative analysis of nanostructured CuS NPs against inhibition of different cancer cells
Human Non Small Cell Lung Cancer Cells A549, supplied by System Biosciences Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human non-small cell lung cancer cells a549/product/System Biosciences Inc
Average 90 stars, based on 1 article reviews
human non-small cell lung cancer cells a549 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
National Research Council Canada human non-small-cell lung cancer cell line a549
Effect of D. japonica Mucus Treatment on Cell Growth. ( a ) A representative experiment demonstrating the dose-dependent impact of mucus treatment on NCI-H358 and 16HBE14o cell numbers, assessed via crystal violet assay 48 h post-treatment. Each point reflects the mean value (±SD) of three independent samples, normalized to their respective controls. ** = p < 0.01, calculated using Student’s t -test. The inset displays EC50 values determined using the Graphpad Prism program. ( b ) This representative experiment illustrates the influence of various mucus preparations on NCI-H358 cell growth, evaluated through crystal violet assay 48 h post-treatment. Each bar represents the mean absorbance (±SD) of three independent samples. NS indicates not significant, determined by one-way ANOVA. ( c ) A representative experiment illustrating the dose-dependent impact of mucus treatment on cell numbers in <t>A549,</t> Caco-2, and THP-1 cells. Cell numbers were assessed using the crystal violet assay for A549 and Caco-2 cells, and direct counting for THP-1 cells, 48 h post-treatment. Each bar represents the mean value (±SD) of three independent samples, normalized to their respective controls. ** = p < 0.01, calculated by Student’s t -test. ( d ) Representative experiment, in which we observe the dose-dependent effect of mucus treatment on cell death, evaluated using the PI incorporation assay in A549, Caco-2, and THP-1 cells, 48 h post-treatment. Each bar represents the percentage of dead and alive cells (±SD) assessed in three independent samples. * = p < 0.05; ** = p < 0.01, determined by Student’s t -test.
Human Non Small Cell Lung Cancer Cell Line A549, supplied by National Research Council Canada, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human non-small-cell lung cancer cell line a549/product/National Research Council Canada
Average 90 stars, based on 1 article reviews
human non-small-cell lung cancer cell line a549 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
BioTherapeutics Inc human lung cancer cell lines a549
A novel tumor-selective oncolytic VVL-m12 replicates efficiently in and is cytotoxic to lung cancer cell lines. (A) Vaccinia virus Lister strain with deletions of the thymidine kinase (TK) and N1L genes has been described previously . We retained the original B5R gene and placed the signal peptide, stalk (S), transmembrane (T) and cytoplasmic tail (C) regions (STC) in the deleted four short consensus repeat (SCR) domains under an H5 promoter control within the TK region to obtain VV CTRL . IL-12 (murine (m) or human (h)) was incorporated into the N1L region of VV CTRL under control of the H5 promoter, creating VVL-m/h12. (B) Cytotoxicity of VVLΔTKΔN1L, VV CTRL and VVL-m12 against murine lung cancer LLC, CMT64, CMT167 and <t>CMT170</t> cells and normal murine NIH3T3 cells. Cell death was determined by MTS assay 144 hours post-infection. EC50 values ± SEM are shown. One-way ANOVA with post hoc Tukey tests were used to assess significance (n=3/group). (C, D) Production of infectious virions after infection of murine lung cancer cell lines and normal murine cells over time. Virus production from whole cell lysates was assessed (C) and EEV production was determined via titration of viral supernatant from the same experiments (D) . Mean PFU/cell ± SEM is shown at each time-point and statistical significance determined using two-way ANOVA with Tukey’s multiple comparison post-test (n=3/group). (E) IL-12 expression after infection of murine lung cancer cell lines at an MOI of 1 PFU/cell. Supernatant was collected every 24 hours for 72 hours and assayed for IL-12 by ELISA. Data were normalized to cell number infected and displayed as ng/2×10 5 cells. n=3/group. In all cases, the mean ± SEM is shown. *p<0.05; **p<0.01; ***p<0.001; ****p<0.0001.
Human Lung Cancer Cell Lines A549, supplied by BioTherapeutics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human lung cancer cell lines a549/product/BioTherapeutics Inc
Average 90 stars, based on 1 article reviews
human lung cancer cell lines a549 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


Comparative analysis of nanostructured CuS NPs against inhibition of different cancer cells

Journal: IET Nanobiotechnology

Article Title: Facile hydrothermal bio‐synthesis of cellulose acetate templated CuS nanorods like fibres: antibacterial, cytotoxicity effects and DNA cleavage properties against A549 lung cancer cells

doi: 10.1049/iet-nbt.2019.0193

Figure Lengend Snippet: Comparative analysis of nanostructured CuS NPs against inhibition of different cancer cells

Article Snippet: Ltd., Chennai for cell line lung cancer (A549) samples and for other biological activities.

Techniques: Inhibition

% of inhibition of A549 cancer cells by anti‐proliferative assay

Journal: IET Nanobiotechnology

Article Title: Facile hydrothermal bio‐synthesis of cellulose acetate templated CuS nanorods like fibres: antibacterial, cytotoxicity effects and DNA cleavage properties against A549 lung cancer cells

doi: 10.1049/iet-nbt.2019.0193

Figure Lengend Snippet: % of inhibition of A549 cancer cells by anti‐proliferative assay

Article Snippet: Ltd., Chennai for cell line lung cancer (A549) samples and for other biological activities.

Techniques: Inhibition

Microscopic images of A549 cancer cells upon treatment with IC50 concentration of biosynthesised CuS nanofibres at different concentration levels

Journal: IET Nanobiotechnology

Article Title: Facile hydrothermal bio‐synthesis of cellulose acetate templated CuS nanorods like fibres: antibacterial, cytotoxicity effects and DNA cleavage properties against A549 lung cancer cells

doi: 10.1049/iet-nbt.2019.0193

Figure Lengend Snippet: Microscopic images of A549 cancer cells upon treatment with IC50 concentration of biosynthesised CuS nanofibres at different concentration levels

Article Snippet: Ltd., Chennai for cell line lung cancer (A549) samples and for other biological activities.

Techniques: Concentration Assay

Effect of D. japonica Mucus Treatment on Cell Growth. ( a ) A representative experiment demonstrating the dose-dependent impact of mucus treatment on NCI-H358 and 16HBE14o cell numbers, assessed via crystal violet assay 48 h post-treatment. Each point reflects the mean value (±SD) of three independent samples, normalized to their respective controls. ** = p < 0.01, calculated using Student’s t -test. The inset displays EC50 values determined using the Graphpad Prism program. ( b ) This representative experiment illustrates the influence of various mucus preparations on NCI-H358 cell growth, evaluated through crystal violet assay 48 h post-treatment. Each bar represents the mean absorbance (±SD) of three independent samples. NS indicates not significant, determined by one-way ANOVA. ( c ) A representative experiment illustrating the dose-dependent impact of mucus treatment on cell numbers in A549, Caco-2, and THP-1 cells. Cell numbers were assessed using the crystal violet assay for A549 and Caco-2 cells, and direct counting for THP-1 cells, 48 h post-treatment. Each bar represents the mean value (±SD) of three independent samples, normalized to their respective controls. ** = p < 0.01, calculated by Student’s t -test. ( d ) Representative experiment, in which we observe the dose-dependent effect of mucus treatment on cell death, evaluated using the PI incorporation assay in A549, Caco-2, and THP-1 cells, 48 h post-treatment. Each bar represents the percentage of dead and alive cells (±SD) assessed in three independent samples. * = p < 0.05; ** = p < 0.01, determined by Student’s t -test.

Journal: Biomolecules

Article Title: Planarian Mucus: A Novel Source of Pleiotropic Cytotoxic and Cytostatic Agents against Cancer Cells

doi: 10.3390/biom14091075

Figure Lengend Snippet: Effect of D. japonica Mucus Treatment on Cell Growth. ( a ) A representative experiment demonstrating the dose-dependent impact of mucus treatment on NCI-H358 and 16HBE14o cell numbers, assessed via crystal violet assay 48 h post-treatment. Each point reflects the mean value (±SD) of three independent samples, normalized to their respective controls. ** = p < 0.01, calculated using Student’s t -test. The inset displays EC50 values determined using the Graphpad Prism program. ( b ) This representative experiment illustrates the influence of various mucus preparations on NCI-H358 cell growth, evaluated through crystal violet assay 48 h post-treatment. Each bar represents the mean absorbance (±SD) of three independent samples. NS indicates not significant, determined by one-way ANOVA. ( c ) A representative experiment illustrating the dose-dependent impact of mucus treatment on cell numbers in A549, Caco-2, and THP-1 cells. Cell numbers were assessed using the crystal violet assay for A549 and Caco-2 cells, and direct counting for THP-1 cells, 48 h post-treatment. Each bar represents the mean value (±SD) of three independent samples, normalized to their respective controls. ** = p < 0.01, calculated by Student’s t -test. ( d ) Representative experiment, in which we observe the dose-dependent effect of mucus treatment on cell death, evaluated using the PI incorporation assay in A549, Caco-2, and THP-1 cells, 48 h post-treatment. Each bar represents the percentage of dead and alive cells (±SD) assessed in three independent samples. * = p < 0.05; ** = p < 0.01, determined by Student’s t -test.

Article Snippet: The human non-small-cell lung cancer cell line A549 and the human bronchioalveolar carcinoma cell line NCI-H358 were kindly provided by Doctor Laura Poliseno from the Italian National Research Council of Pisa.

Techniques: Crystal Violet Assay

A novel tumor-selective oncolytic VVL-m12 replicates efficiently in and is cytotoxic to lung cancer cell lines. (A) Vaccinia virus Lister strain with deletions of the thymidine kinase (TK) and N1L genes has been described previously . We retained the original B5R gene and placed the signal peptide, stalk (S), transmembrane (T) and cytoplasmic tail (C) regions (STC) in the deleted four short consensus repeat (SCR) domains under an H5 promoter control within the TK region to obtain VV CTRL . IL-12 (murine (m) or human (h)) was incorporated into the N1L region of VV CTRL under control of the H5 promoter, creating VVL-m/h12. (B) Cytotoxicity of VVLΔTKΔN1L, VV CTRL and VVL-m12 against murine lung cancer LLC, CMT64, CMT167 and CMT170 cells and normal murine NIH3T3 cells. Cell death was determined by MTS assay 144 hours post-infection. EC50 values ± SEM are shown. One-way ANOVA with post hoc Tukey tests were used to assess significance (n=3/group). (C, D) Production of infectious virions after infection of murine lung cancer cell lines and normal murine cells over time. Virus production from whole cell lysates was assessed (C) and EEV production was determined via titration of viral supernatant from the same experiments (D) . Mean PFU/cell ± SEM is shown at each time-point and statistical significance determined using two-way ANOVA with Tukey’s multiple comparison post-test (n=3/group). (E) IL-12 expression after infection of murine lung cancer cell lines at an MOI of 1 PFU/cell. Supernatant was collected every 24 hours for 72 hours and assayed for IL-12 by ELISA. Data were normalized to cell number infected and displayed as ng/2×10 5 cells. n=3/group. In all cases, the mean ± SEM is shown. *p<0.05; **p<0.01; ***p<0.001; ****p<0.0001.

Journal: Frontiers in Immunology

Article Title: A novel oncolytic Vaccinia virus armed with IL-12 augments antitumor immune responses leading to durable regression in murine models of lung cancer

doi: 10.3389/fimmu.2024.1492464

Figure Lengend Snippet: A novel tumor-selective oncolytic VVL-m12 replicates efficiently in and is cytotoxic to lung cancer cell lines. (A) Vaccinia virus Lister strain with deletions of the thymidine kinase (TK) and N1L genes has been described previously . We retained the original B5R gene and placed the signal peptide, stalk (S), transmembrane (T) and cytoplasmic tail (C) regions (STC) in the deleted four short consensus repeat (SCR) domains under an H5 promoter control within the TK region to obtain VV CTRL . IL-12 (murine (m) or human (h)) was incorporated into the N1L region of VV CTRL under control of the H5 promoter, creating VVL-m/h12. (B) Cytotoxicity of VVLΔTKΔN1L, VV CTRL and VVL-m12 against murine lung cancer LLC, CMT64, CMT167 and CMT170 cells and normal murine NIH3T3 cells. Cell death was determined by MTS assay 144 hours post-infection. EC50 values ± SEM are shown. One-way ANOVA with post hoc Tukey tests were used to assess significance (n=3/group). (C, D) Production of infectious virions after infection of murine lung cancer cell lines and normal murine cells over time. Virus production from whole cell lysates was assessed (C) and EEV production was determined via titration of viral supernatant from the same experiments (D) . Mean PFU/cell ± SEM is shown at each time-point and statistical significance determined using two-way ANOVA with Tukey’s multiple comparison post-test (n=3/group). (E) IL-12 expression after infection of murine lung cancer cell lines at an MOI of 1 PFU/cell. Supernatant was collected every 24 hours for 72 hours and assayed for IL-12 by ELISA. Data were normalized to cell number infected and displayed as ng/2×10 5 cells. n=3/group. In all cases, the mean ± SEM is shown. *p<0.05; **p<0.01; ***p<0.001; ****p<0.0001.

Article Snippet: Mouse CMT167, as well as CMT170 lung cancer cell line, human lung cancer cell lines H1299 and A549 and non-cancerous cell lines NIH3T3 (murine) and NHBE (human) were obtained from the Centre for Biomarkers & Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, UK.

Techniques: Virus, Control, MTS Assay, Infection, Titration, Comparison, Expressing, Enzyme-linked Immunosorbent Assay